Ares Acquisition [AACT] vs Inflection Point [IPXX] Detailed Stock Comparison

TLDR: Quick Comparison Summary

We found some data (4 metrics), but not enough for a complete comparison. Metrics like P/E ratio, profitability, and financial health are still available in the detailed tabs below.

View Metrics Details

Vital Metrics Comparison

Note: Limited metrics are available for comparison. Check other tabs for more detailed analysis.

MetricAres AcquisitionInflection PointBetter
P/E Ratio (TTM)36.50N/AN/A
Price-to-Book Ratio0.860.64Inflection Point
Debt-to-Equity Ratio0.010.00Inflection Point
PEG Ratio-0.40N/AN/A
EV/EBITDA-20.13N/AN/A
Profit Margin (TTM)0.00%N/AN/A
Operating Margin (TTM)0.00%N/AN/A
Return on Equity4.92%N/AN/A
Return on Assets (TTM)-1.04%N/AN/A
Free Cash Flow (TTM)$-929,804N/AN/A
1-Year Return-31.46%70.69%Inflection Point
Enterprise Value$594.62M$0Ares Acquisition
Revenue per Share (TTM)$0N/AN/A
Earnings per Share (Diluted)$0.26N/AN/A
Beta (Stock Volatility)-0.01N/AN/A
Performance
News Sentiment
Key Stats
Valuation
Financials
Short Interest
Dividends

Ares Acquisition vs Inflection Point Stock Performance Analysis

Loading Price Chart...

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Ares Acquisition8.78%8.63%-34.88%-34.25%-33.30%-32.27%
Inflection Point14.31%49.80%88.66%161.43%299.38%109.86%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Ares Acquisition-31.46%-26.51%-26.51%-26.51%-26.51%-26.51%
Inflection Point70.69%81.64%81.64%81.64%81.64%81.64%

News Based Sentiment: Ares Acquisition vs Inflection Point

Ares Acquisition

News based Sentiment: MIXED

The month saw significant funding secured for the Ares/Kodiak merger, alongside substantial institutional investment. However, the stock experienced volatility and analysts maintain a 'Hold' rating, creating a mixed investment narrative. The upcoming shareholder meeting is a key catalyst.

View Ares Acquisition News Sentiment Analysis

Inflection Point

News based Sentiment: NEUTRAL

The month's narrative centers around increased visibility for IPXX as a small-cap stock, but the reports also highlight the inherent risks of this market segment. While positive in terms of attention, the overall impact on the investment case is neutral, requiring further investigation.

View Inflection Point News Sentiment Analysis

Performance & Financial Health Analysis: Ares Acquisition vs Inflection Point

MetricAACTIPXX
Market Information
Market Cap i$421.26M$811.25M
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i870,23311,317,539
90 Day Avg. Volume i607,1186,956,464
Last Close$7.43$25.96
52 Week Range$5.77 - $11.62$5.56 - $28.25
% from 52W High-36.06%-8.11%
All-Time High$11.62 (Jun 02, 2025)$28.25 (Oct 03, 2025)
% from All-Time High-36.06%-8.11%
Growth Metrics
Quarterly Revenue GrowthN/AN/A
Quarterly Earnings Growth-0.95%N/A
Financial Health
Profit Margin (TTM) i0.00%N/A
Operating Margin (TTM) i0.00%N/A
Return on Equity (TTM) i0.05%N/A
Debt to Equity (MRQ) i0.010.00
Cash & Liquidity
Book Value per Share (MRQ)$-0.39$40.57
Cash per Share (MRQ)$0.00$0.02
Operating Cash Flow (TTM) i$-2,491,593$0
Levered Free Cash Flow (TTM) i$942,876$0
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend iN/AN/A

Valuation & Enterprise Metrics Analysis: Ares Acquisition vs Inflection Point

MetricAACTIPXX
Price Ratios
P/E Ratio (TTM) i36.50N/A
Forward P/E iN/AN/A
PEG Ratio i-0.40N/A
Price to Sales (TTM) iN/AN/A
Price to Book (MRQ) i0.860.64
Market Capitalization
Market Capitalization i$421.26M$811.25M
Enterprise Value i$594.62M$0
Enterprise Value Metrics
Enterprise to Revenue iN/AN/A
Enterprise to EBITDA i-20.13N/A
Risk & Other Metrics
Beta i-0.01N/A
Book Value per Share (MRQ) i$-0.39$40.57

Financial Statements Comparison: Ares Acquisition vs Inflection Point

Financial Metrics

Loading Financial Charts...

Revenue

EBITDA

Shareholders Equity

Operating Margin

Free Cash Flow

Long Term Debt

Profit Margin

Current Ratio

Operating Cash Flow

Income Statement (MRQ)

Metric (MRQ)AACTIPXX
Revenue/Sales i$0$0
Cost of Goods Sold iN/AN/A
Gross Profit iN/AN/A
Research & Development iN/AN/A
Operating Income (EBIT) i$-2.71M$-1.92M
EBITDA i$-8.40M$-5.35M
Pre-Tax Income i$2.99M$1.51M
Income Tax iN/AN/A
Net Income (Profit) i$2.99M$1.51M

Balance Sheet & Liquidity Metrics (MRQ)

Metric (MRQ)AACTIPXX
Cash & Equivalents i$657,314$141,201
Total Current Assets i$747,611$222,948
Total Current Liabilities i$3.09M$2.73M
Long-Term Debt i$5.00MN/A
Total Shareholders Equity i$531.65M$253.54M
Retained Earnings i$-24.75M$-15.60M
Property, Plant & Equipment iN/AN/A

Cash Flow Statement Comparison (MRQ)

Metric (MRQ)AACTIPXX
Operating Cash Flow i$2.99M$1.51M
Capital Expenditures iN/AN/A
Free Cash Flow i$-318,005$-490,386
Debt Repayment iN/A$0
Common Stock Repurchase iN/AN/A

Short Interest & Institutional Ownership Analysis

MetricAACTIPXX
Shares Short i26,618N/A
Short Ratio i0.10N/A
Short % of Float i0.00%N/A
Average Daily Volume (10 Day) i870,23311,317,539
Average Daily Volume (90 Day) i607,1186,956,464
Shares Outstanding i62.50M31.25M
Float Shares i39.98MN/A
% Held by Insiders iN/AN/A
% Held by Institutions iN/AN/A

Dividend Analysis & Yield Comparison: Ares Acquisition vs Inflection Point

MetricAACTIPXX
Last 12-Month Dividend iN/AN/A
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend iN/AN/A
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends iN/AN/A
Ex-Dividend DateN/AN/A